New discovery in the fight against Huntington’s diseaseNovember 28th, 2010 - 11:31 am ICT by ANI
Washington, Nov 28 (ANI): Scientists have made a novel discovery in the fight against Huntington’s disease (HD).
HD is an incurable progressive neurodegenerative genetic disorder which affects motor coordination and leads to cognitive decline and dementia.
The disease pathology stems from a mutation in the huntingtin (Htt) gene, which results in the accumulation of toxic proteins leading to neuronal cell death.
Previous studies have clearly implicated caspases - enzymes that break down cells - as key players in the cascade of events involved in HD neuronal death.
Now scientists have identified three small molecules that inhibit the activity of those caspases, suppressing toxicity and rescuing neurons from cell death in cell culture.
The research was led by both Buck Institute faculty member Lisa Ellerby, and Yale University faculty member Jonathan Ellman. Dr. Ellerby is doing follow up studies in a mouse model of the disease.
Dr. Ellerby said a substrate based screening method was used to identify compounds that reacted with caspases. Based on those reactions, Jonathan Ellman, from the Yale University Department of Chemistry, converted the compounds to caspase inhibitors.
Dr. Ellerby said that the inhibitors are based on properties of a drug, which had entered Phase I clinical trials for the treatment of human liver preservation injury.
“These molecules shows particular promise. They cross the blood-brain barrier and acts selectively to block the processes involved in HD,” said Ellerby.
Dr. Ellerby said the caspase inhibitors both suppressed the proteolysis of Htt and rescued HD neurons that have begun to undergo cell death.
“We believe this is going to help us move the field forward because now we can test these compounds in live animals. Up until this point we have not identified a caspase inhibitor that has acted selectively against the toxic effects of the Htt mutation,” said Dr. Ellerby.
The study appears in the November 24th edition of Chemistry and Biology. (ANI)
- Why Huntington's disease symptoms take so long to appear - Feb 24, 2010
- Potential therapeutic target for Parkinson's, Alzheimer's identified - Mar 12, 2011
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Novel therapeutic target for Huntington's disease identified - Dec 25, 2009
- Scientists using gene therapy to stall Huntington's disease - Nov 01, 2009
- Molecular switch to thwart Huntington's disease found - Dec 25, 2009
- Study finds enzyme that is 'the killer you can't live without' - Mar 04, 2011
- Strawberries show promise against Huntington's disease - Nov 16, 2010
- Yeast offers clues to Parkinson's disease - Sep 09, 2010
- Infrared light heals vision damaged by Parkisnon's - Aug 03, 2012
- Faulty clean-up process may be Huntington's disease key - Apr 12, 2010
- New discovery shows promise against non-small cell lung cancer - Dec 04, 2010
- New way to kill cancer cells discovered - Sep 18, 2011
- Scientists make anti-cancer compounds - Feb 13, 2010
- Misfolding neural proteins linked with autism - Sep 13, 2010
Tags: blood brain barrier, buck institute, caspase inhibitors, cognitive decline, department of chemistry, disease pathology, ellerby, htt gene, human liver, institute faculty, motor coordination, neuronal cell death, neuronal death, new discovery, preservation injury, screening method, toxic proteins, university faculty member, yale university department, yale university faculty